Post job

Explore jobs

Find specific jobs

Explore careers

Explore professions

Best companies

Explore companies

Cardium Therapeutics CEO and leadership

Zippia score 3.7
OverviewRevenue

Reviews

CEO & Executives

Cardium Therapeutics CEO and executives

Executive Summary. Based on our data team's research, Christopher J. Reinhard is the Cardium Therapeutics's CEO. Cardium Therapeutics has 30 employees, of which 7 are in a leadership position.
Work at Cardium Therapeutics?
Share your experience

Rate Cardium Therapeutics' leadership communication with employees.

Zippia waving zebra
Name & TitleBio
Christopher J. Reinhard

Founder, Chairman of Board and Chief Executive Officer

Christopher J. Reinhard's LinkedIn

Chris Reinhard is a Chief Executive Officer at Activation Therapeutics Inc, Chief Executive Officer (formerly Collateral Therapeutics) at Angiogonetics Therapeutics, and Chief Executive Officer at LifeAgain Advanced Medical Data Analytics and is based in San Diego, California. He has worked as Managing Director & Vice President at Henley Group; Chief Executive Officer at InnerCool Therapeutics, Inc.; and Assistant Treasurer / Director Special Projects at Signal AI.

Andrew Leitch

Board Member

Gabor Rubanyi

Chief Scientific Officer

Gabor Rubanyi's LinkedIn

Gabor Rubanyi is a Chief Scientific Officer at Approaching the Clinic: Nitrite and Nitrate Pathophysiology and Therapy and Chief Scientific officer at Cardium Therapeutics Inc.. He has worked as Head of Pharmacology at Schering AG and VP Gene Therapy at Berlex Biosciences. Gabor attended Washington University, St Louis, MO between 1974 and 1976 and Semmelweis Egyetem between 1965 and 1971.

James L. Grainer

Chairman & Chief Financial Officer

Kaushik K. Vyas

Board Member

Lois A. Chandler

Chief Operating Officer

Ronald J. Shebuski

Chief Scientific Officer

Do you work at Cardium Therapeutics?

Does leadership effectively guide Cardium Therapeutics toward its goals?

Cardium Therapeutics jobs

Cardium Therapeutics founders

Name & TitleBio
Christopher J. Reinhard

Founder, Chairman of Board and Chief Executive Officer

Christopher J. Reinhard's LinkedIn

Chris Reinhard is a Chief Executive Officer at Activation Therapeutics Inc, Chief Executive Officer (formerly Collateral Therapeutics) at Angiogonetics Therapeutics, and Chief Executive Officer at LifeAgain Advanced Medical Data Analytics and is based in San Diego, California. He has worked as Managing Director & Vice President at Henley Group; Chief Executive Officer at InnerCool Therapeutics, Inc.; and Assistant Treasurer / Director Special Projects at Signal AI.

Cardium Therapeutics board members

Name & TitleBio
Christopher J. Reinhard

Founder, Chairman of Board and Chief Executive Officer

Christopher J. Reinhard's LinkedIn

Chris Reinhard is a Chief Executive Officer at Activation Therapeutics Inc, Chief Executive Officer (formerly Collateral Therapeutics) at Angiogonetics Therapeutics, and Chief Executive Officer at LifeAgain Advanced Medical Data Analytics and is based in San Diego, California. He has worked as Managing Director & Vice President at Henley Group; Chief Executive Officer at InnerCool Therapeutics, Inc.; and Assistant Treasurer / Director Special Projects at Signal AI.

Andrew Leitch

Board Member

James L. Grainer

Chairman & Chief Financial Officer

Kaushik K. Vyas

Board Member

Cardium Therapeutics executives FAQs

Most in demand jobs

Updated November 18, 2022

Zippia gives an in-depth look into the details of Cardium Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Cardium Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Cardium Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Cardium Therapeutics. The data presented on this page does not represent the view of Cardium Therapeutics and its employees or that of Zippia.

Cardium Therapeutics may also be known as or be related to Cardium Therapeutics, Cardium Therapeutics Inc, Cardium Therapeutics Inc. and Cardium Therapeutics, Inc.